Era Biology will host global live webinar at 12th July. Due to the fact that WHO has declared that antimicrobial resistance (AMR) is one of the top 10 global public health threats facing humanity. ...
Tianjin, China – March 18, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, which is a lead and pioneer of invasive fungal disease diagnostic field since 1997...
A new starting point for the industry standard
Following YY/T 1729-2020 “Fungi (1-3)-β-D glucan determination kit”, YY/T 1793-2021 “Bacterial Endotoxin Determination Kit” fo...
Genobio Successfully Approved by Health Canada for its Aspergillus Rapid Test
Tianjin, China – September 14, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, ...
The second National Academic Conference on Bacterial and Fungal Infections of Chinese Medical Association was successfully held in Guangzhou, July 29-31, 2022. The academic report of the conference...